Publications by authors named "L R Rechtman"
Introduction: Multiple sclerosis (MS) is an immune-mediated central nervous system disorder and a growing global health challenge affecting nearly 3 million people worldwide. Incidence and prevalence continue to increase with no known cause or cure. Globally governments and non-profit organizations fund research toward better understanding of and treatments for multiple sclerosis.
View Article and Find Full Text PDFBackground And Objectives: Recent data suggest increasing global prevalence of multiple sclerosis (MS). Early diagnosis of MS reduces the burden of disability-adjusted life years and associated health care costs. Yet diagnostic delays persist in MS care and even within national health care systems with robust resources, comprehensive registries, and MS subspecialist referral networks.
View Article and Find Full Text PDFArticle Synopsis
- Optical interconnects are emerging as a solution to improve data transfer limits in high-performance silicon chips, focusing on enhancing optical communication through wavelength-division multiplexing.
- The study presents an integrated communication scheme that combines wavelength- and mode-multiplexing, achieving a significant 1.12-Tb/s data transmission without errors in a silicon nanophotonic waveguide.
- Additionally, the approach employs inverse-designed couplers for efficient multimode optical transmission between different silicon chips, while ensuring compliance with standard silicon photonic foundry processes, making it scalable beyond current technologies.
Objective: This research aims to examine the impact of the National Amyotrophic Lateral Sclerosis (ALS) Registry-funded research activities.
Methods: Registry-funded research and related publications were identified through the National ALS Registry website, the National Institutes of Health (NIH) Reporter website, and verified by Principal Investigators. Key study characteristics (e.
Amyotrophic lateral sclerosis (ALS) is a rare neurological condition affecting upper and lower motor neurons. The National ALS Biorepository (referred to as the Biorepository) was initiated in 2015, with biospecimen collection beginning in 2017, as a repository for biospecimens for future ALS research. To help ensure the usefulness of the Biorepository, a biospecimen demand analysis is conducted on an annual basis, as well as an analysis of the utilization of the Biorepository.
View Article and Find Full Text PDF